EUVIMEDEUVIMED entdecken
EditorialOpen Access · CC BY 4.0

Protocols for Randomized Controlled Trials: Advancing Transparency in Infectious Diseases

Jean-Jacques Parienti iD, Roger Bedimo iD, Cynthia L Sears, Paul E Sax

Open Forum Infectious Diseases · 30.03.2026 · 13 (4)

DOI: 10.1093/ofid/ofag163 ↗

Kurz gefasst

Editorial in der Zeitschrift Open Forum Infectious Diseases, online erschienen am 28.04.2026. Verfasst von Jean-Jacques Parienti und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Research, Caen University Hospital, Caen, France. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Department of Clinical Research, Caen University Hospital, Caen, France.
  • Division of Infectious Diseases, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
  • Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Division of Infectious Diseases, Brigham and Women's Hospital, Boston, Massachusetts, USA.

ORCID-Profile: Jean-Jacques Parienti, Roger Bedimo

Zitieren

APA

Parienti, J. J., Bedimo, R., Sears, C. L., & Sax, P. E. (2026). Protocols for Randomized Controlled Trials: Advancing Transparency in Infectious Diseases. Open Forum Infectious Diseases, 13(4). https://doi.org/10.1093/ofid/ofag163

Vancouver

Parienti JJ, Bedimo R, Sears CL, Sax PE. Protocols for Randomized Controlled Trials: Advancing Transparency in Infectious Diseases. Open Forum Infectious Diseases. 2026;13(4). doi:10.1093/ofid/ofag163

BibTeX
@article{Parienti2026,
  author = {Parienti, Jean-Jacques and Bedimo, Roger and Sears, Cynthia L and Sax, Paul E},
  title = {Protocols for Randomized Controlled Trials: Advancing Transparency in Infectious Diseases},
  journal = {Open Forum Infectious Diseases},
  year = {2026},
  volume = {13},
  number = {4},
  doi = {10.1093/ofid/ofag163}
}
Kostenlos starten →